Center-Authored Papers

Filters: Author is Djulbegovic, Benjamin  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Anderson KC, Alsina M, Bensinger WI, Biermann SJ, Chanan-Khan A, Cohen AD, Devine S, Djulbegovic B, Gasparetto C, Huff CA et al..  2009.  NCCN clinical practice guidelines in oncology: multiple myeloma.. Journal of the National Comprehensive Cancer Network : JNCCN. 7(9):908-42.
Anderson KC, Alsina M, Bensinger WI, Biermann SJ, Cohen AD, Devine S, Djulbegovic B, Faber EA, Gasparetto C, Hernandez-Ilizaliturri F et al..  2012.  Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma, Version 2.2013.. Journal of the National Comprehensive Cancer Network : JNCCN. 10(10):1211-1219. Abstract
Anderson KC, Alsina M, Bensinger WI, Biermann SJ, Chanan-Khan A, Cohen AD, Devine S, Djulbegovic B, Faber EA, Gasparetto C et al..  2011.  Multiple myeloma.. Journal of the National Comprehensive Cancer Network : JNCCN. 9(10):1146-83.
Anderson KC, Alsina M, Atanackovic D, Biermann SJ, Chandler JC, Costello C, Djulbegovic B, Fung HC, Gasparetto C, Godby K et al..  2015.  Multiple Myeloma, Version 2.2016.. Journal of the National Comprehensive Cancer Network : JNCCN. 13(11):1398-435. Abstract
Anderson KC, Alsina M, Bensinger WI, Biermann SJ, Cohen AD, Devine S, Djulbegovic B, Faber EA, Gasparetto C, Hernandez-Illizaliturri F et al..  2013.  Multiple Myeloma, Version 1.2013.. Journal of the National Comprehensive Cancer Network : JNCCN. 11(1):11-17. Abstract
Anderson KC, Alsina M, Atanackovic D, Biermann SJ, Chandler JC, Costello C, Djulbegovic B, Fung HC, Gasparetto C, Godby K et al..  2016.  NCCN Guidelines Insights: Multiple Myeloma, Version 3.2016.. Journal of the National Comprehensive Cancer Network : JNCCN. 14(4):389-400. Abstract
C
Clark OAC, Lyman GH, Castro AA, Clark LGO, Djulbegovic B.  2005.  Colony-stimulating factors for chemotherapy-induced febrile neutropenia: a meta-analysis of randomized controlled trials.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 23(18):4198-214. Abstract
D
Djulbegovic B, Lyman GH.  2006.  Screening mammography at 40-49 years: regret or no regret? Lancet. 368(9552):2035-7.
Djulbegovic B, Coleman R, Stahel R, Singh D, Lyman G.  2003.  Evidence-based oncology in cancer treatment reviews.. Cancer treatment reviews. 29(1):45-50.
Djulbegovic B, Hozo I, Lyman GH.  2007.  Estimating net benefits and harms of screening mammography in women age 40 to 49 years.. Annals of internal medicine. 147(12):882.
F
Fletcher JW, Djulbegovic B, Soares HP, Siegel BA, Lowe VJ, Lyman GH, Coleman ER, Wahl R, Paschold JC, Avril N et al..  2008.  Recommendations on the use of 18F-FDG PET in oncology.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 49(3):480-508. Abstract
H
Herold CI, Djulbegovic B, Hozo I, Lyman GH.  2010.  Reliable data on 5- and 10-year survival provide accurate estimates of 15-year survival in estrogen receptor-positive early-stage breast cancer.. Breast cancer research and treatment. 121(3):771-6. Abstract
Hozo I, Djulbegovic B, Clark O, Lyman GH.  2005.  Use of re-randomized data in meta-analysis.. BMC medical research methodology. 5:17. Abstract
K
Kharfan-Dabaja MA, Hamadani M, Reljic T, Nishihori T, Bensinger WI, Djulbegovic B, Kumar A.  2013.  Comparative efficacy of tandem autologous versus autologous followed by allogeneic hematopoietic cell transplantation in patients with newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trials.. Journal of hematology & oncology. 6:2. Abstract
L
Lyman GH, Djulbegovic B.  2005.  The challenge of systematic reviews of diagnostic and staging studies in cancer.. Cancer treatment reviews. 31(8):628-39. Abstract
Lyman GH, Kuderer NM, Djulbegovic B.  2002.  Prophylactic granulocyte colony-stimulating factor in patients receiving dose-intensive cancer chemotherapy: a meta-analysis.. The American journal of medicine. 112(5):406-11. Abstract
S
Schroen AT, Petroni GR, Wang H, Thielen MJ, Sargent D, Benedetti JK, Cronin WM, Wickerham DL, Wang XF, Gray R et al..  2011.  Challenges to accrual predictions to phase III cancer clinical trials: a survey of study chairs and lead statisticians of 248 NCI-sponsored trials.. Clinical trials (London, England). 8(5):591-600. Abstract
Schroen AT, Petroni GR, Wang H, Thielen MJ, Gray R, Benedetti JK, Wang X, Sargent DJ, Wickerham DL, Cronin WM et al..  2012.  Achieving Sufficient Accrual to Address the Primary Endpoint in Phase III Clinical Trials from US Cooperative Oncology Groups.. Clinical cancer research : an official journal of the American Association for Cancer Research. 18(1):256-262. Abstract
Schroen AT, Petroni GR, Wang H, Gray R, Wang XF, Cronin W, Sargent DJ, Benedetti JK, Wickerham DL, Djulbegovic B et al..  2010.  Preliminary evaluation of factors associated with premature trial closure and feasibility of accrual benchmarks in phase III oncology trials.. Clinical trials (London, England). 7(4):312-21. Abstract
Schully SD, Lam TK, Dotson DW, Chang CQ, Aronson N, Birkeland ML, Brewster SJ, Boccia S, Buchanan AH, Calonge N et al..  2014.  Evidence synthesis and guideline development in genomic medicine: current status and future prospects.. Genetics in medicine : official journal of the American College of Medical Genetics. Abstract